-
Cathay Biotech Plans $901M Private Placement to Boost Bio-Based Materials
•
Shanghai-based Cathay Biotech Inc. (SHA: 688065) has announced plans to raise RMB 6.6 billion (USD 901 million) through a private placement of 153,595,531 shares at RMB 42.97 (USD 5.86) per share. This significant capital raise is aimed at enhancing the company’s capabilities in the research, development, manufacturing, and sales of…
-
MoleculeMind Raises Over RMB 100 Million for AI Protein Design Platform
•
MoleculeMind, an artificial intelligence (AI)-empowered protein design platform based in Beijing, has reportedly raised over RMB 100 million (USD 14.58 million) in its latest financing round. The round was led by Cathay Biotech Inc. (SHA: 688065), a synthetic biology firm based in Shanghai, with contributions from Lenovo Capital and Sequoia…
